Bio-Techne Corp. (TECH), a life sciences company, announced Tuesday that it has won a second claim of reverse engineering by Miltenyi ...
This is why it is of great interest to develop methods that make it possible to experimentally characterize exosomes. Miltenyi Biotec's new MACSPlex Exosome kit, human enables the qualitative as well ...
In this virtual symposium Miltenyi Biotec researchers and customers share their experiences along the CAR T cell and CAR NK cell development and manufacturing path. Scientists and clinicians will get ...
MINNEAPOLIS, Jan. 7, 2025 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that it prevailed on another claim that Miltenyi Biotec ... Regional Court, Germany (docket no ...